Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

RSV vaccine for pregnant women protects their newborns but is it ready for US sale?

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy

The Independent UK

The Newest FDA-Approved Injectable, SKINVIVE, Is Unlike Anything on the Market

“This is an important, watershed moment in injectable filler development.”

Marie Claire

How Charlotte Allerton Helped Win A Key Battle Against Covid-19

Charlotte Allerton was ready for action when the pandemic hit. She led a team of Pfizer scientists to develop Paxlovid as the first oral antiviral treatment for Covid-19.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

The abortion pill mifepristone has another day in federal court

While a Supreme Court order continues to ensure the drug is still widely available, the issue returned Wednesday to the Fifth Circuit Court of Appeals as lawyers for both sides urged the court to act.

WEKU

Republican-appointed federal judges grill FDA in mifepristone hearing

A legal challenge against a widely used abortion drug could be headed to the Supreme Court

The Independent UK

Appeals court weighs FDA approval of abortion drug - Roll Call

The oral arguments in the abortion drug case are the latest in what has become the next front in the battle over abortion.

Roll Call

Federal appeals court seems skeptical of FDA's abortion pill approval

The court is likely to issue a final decision in the coming weeks.

Axios

Read news from The Economist, FT, and more,
with one subscription

New hope for an antidote to death cap mushrooms and other poison fungi

The death cap mushroom is one of the deadliest poison fungi on earth. Few effective treatments are available. But a team of Chinese and Australian scientists say they've made a leap forward.

WEKU

Beyond the 'abortion pill': Real-life experiences of individuals taking mifepristone

Ahead of oral arguments in a federal appeals court over access to mifepristone, more than 150 people shared stories with NPR about how they used the medication — and how it changed their lives.

WEKU

First Thing: Quad summit cancelled after Joe Biden calls off trip to Australia

Leaders will instead meet on sidelines of G7 in Hiroshima this weekend. Plus, how mifepristone became a target of the US anti-abortion movement

The Guardian - UK

How mifepristone became a target of the US anti-abortion movement

The abortion pill, first invented in 1980 in France, was slow to be accepted in the US. Now, it’s at the center of a major court fight

The Guardian - US

Abortion pill case moves to appeals court, on track for Supreme Court

A federal appeals court in New Orleans hears arguments Wednesday on whether a drug used in the most common method of abortion was properly approved by a government agency more than two decades ago

The Independent UK

OpenAI Chief Sam Altman Wants an FDA-Style Agency for Artificial Intelligence

His licensing proposal would slow down A.I. innovation without really reducing A.I. risks.

Reason

An Innocuous Dye Could Hold the Antidote to the World’s Deadliest Mushroom

The death cap mushroom (Amanita phalloides) is responsible for the most food poisoning deaths worldwide. Scientists used CRISPR to identify a potential antidote.

Inverse

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Gay men can now donate blood after FDA changes decades-old rule – a health policy researcher explains the benefits

The U.S. Food and Drug Administration announced on May 11, 2023, that it has officially dropped restrictions that prohibit gay and bisexual men from donating blood under many circumstances on May 11, 2023. The ban was initially put in place in the early days of the AIDS epidemic, but for…

The Street

Sarepta Therapeutics Stock Skyrockets On FDA Surprise

A promising gene therapy got welcome news from regulators.

The Street

FDA Group Backs Gene Therapy to Fight Degenerative Disease

A promising gene therapy got welcome news from regulators.

LiveScience

1st-of-its-kind menopause drug targets brain misfiring behind hot flashes

The U.S. Food and Drug Administration approved a new pill for moderate to severe hot flashes.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Families scramble to find growth hormone drug as shortage drags on

Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.

Axios

The biggest startup flameouts of the last decade

Vice now joins an ignominious club of well-funded flameouts.

Inverse

Menstrual Products Are Wildly Unregulated — Here’s What to Watch Out For

Amid calls for more disclosure and research into the health effects of these products, some states require more transparency.

The Independent UK

Restaurant’s sushi roll blamed for poisoning 41 and killing 2

The fatal victims ordered the “special roll,” which contained salmon and morel mushrooms

Investors Business Daily

Dow Jones Futures Rise In Dangerous Market; Sarepta Soars On FDA News

Sideways action is far more dangerous than a bear market because it lures investors in. Here's what to do now. Sarepta surged on an FDA panel vote.

The Independent UK

New menopause drug for hot flashes gets FDA approval

The Food and Drug Administration has approved a new type of drug to treat hot flashes caused by menopause

Investors Business Daily

Sarepta Stock Catapults Higher After Eking Out A Narrow Win In Its Gene Therapy Battle

Shares of SRPT stock launched Monday after FDA advisors voted late Friday in support of a highly anticipated gene therapy from Sarepta.

1 … 78 79 80 81

People

Ramesh ‘Sunny’ Balwani

63 stories

James Ho

41 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.